Skip to content

Closed-Loop Oxygen Control

Optimization of parameters of automatic Fraction of Inspired Oxygen (FiO2) control for use with preterm patients - Closed-Loop Oxygen Control

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57577
Enrollment
66
Registered
2024-12-12
Start date
2025-08-14
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Newborn respiratory distress syndrome Breathing problems in newborn babies

Interventions

Automated control of the FiO2 based on the measured SpO2 for 72 hours.

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Admitted to the NICU in the Erasmus MC, Rotterdam- Gestational age <37 weeks.- Receiving respiratory support (invasive, non-invasive or high flow) and a FiO2 of > 21%.- Written informed parental informed c

Exclusion criteria

Exclusion criteria: Congenital or chromosomal defects.- Transfer of the patient within 24 hours- Expected switch of ventilation mode (invasive to non invasive, non-invasive to high flow) within 72 hours- Patients on High Frequency Oscillation- Patients receiving Nitrous Oxide (NO) therapy.- Suspicion of NEC- Planned surgery within 4 days of start study protocol

Design outcomes

Primary

MeasureTime frame
The main objective of the study is to determine, what is the best algorithm (Day 1:Manual oxygen control, Day 2: Closed-loop oxygen control), defined as the algorithm with the lowest area outside of the patient Spo2 target range?

Secondary

MeasureTime frame
Secondary outcomes are among others the time spend within the target range, the number of hyper and hypoxic events, average maximum and minimum SpO2 during these events, number of FiO2 adjustments (manual and automated) and cerebral oxygen saturation when available.

Countries

Netherlands

Contacts

Public ContactJ.J Wisse- Smit

Erasmus MC, Universitair Medisch Centrum Rotterdam

j.j.smit@erasmusmc.nl+31681304650

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 9, 2026